Latest New Leaf Venture Partners, L.L.C. Stock Portfolio
New Leaf Venture Partners, L.L.C. Performance:
2024 Q3: 12.8%YTD: -2.85%2023: -1.15%
Performance for 2024 Q3 is 12.8%, and YTD is -2.85%, and 2023 is -1.15%.
About New Leaf Venture Partners, L.L.C. and 13F Hedge Fund Stock Holdings
New Leaf Venture Partners, L.L.C. is a hedge fund based in NEW YORK, NY. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $605.5 Millions. In it's latest 13F Holdings report, New Leaf Venture Partners, L.L.C. reported an equity portfolio of $97.3 Millions as of 30 Sep, 2024.
The top stock holdings of New Leaf Venture Partners, L.L.C. are EWTX, ARVN, CRNX. The fund has invested 42.6% of it's portfolio in EDGEWISE THERAPEUTICS INC and 36.3% of portfolio in ARVINAS INC.
The fund showed a lot of confidence in some stocks as they added substantially to ITERUM THERAPEUTICS PLC (ITRM) and ARVINAS INC (ARVN).
The top stock holdings of New Leaf Venture Partners, L.L.C. are EWTX, ARVN, CRNX. The fund has invested 42.6% of it's portfolio in EDGEWISE THERAPEUTICS INC and 36.3% of portfolio in ARVINAS INC.
The fund showed a lot of confidence in some stocks as they added substantially to ITERUM THERAPEUTICS PLC (ITRM) and ARVINAS INC (ARVN).
New Leaf Venture Partners, L.L.C. Annual Return Estimates Vs S&P 500
Our best estimate is that New Leaf Venture Partners, L.L.C. made a return of 12.8% in the last quarter. In trailing 12 months, it's portfolio return was 42.19%.
New Buys
Additions
| Ticker | % Inc. |
|---|---|
| iterum therapeutics plc | 255 |
| arvinas inc | 11.26 |
Additions to existing portfolio by New Leaf Venture Partners, L.L.C.
Reductions
Sold off
Sector Distribution
New Leaf Venture Partners, L.L.C. has about 100% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 100 |
Market Cap. Distribution
New Leaf Venture Partners, L.L.C. has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 86.2 |
| MID-CAP | 7.4 |
| MICRO-CAP | 6 |
Stocks belong to which Index?
About 97.8% of the stocks held by New Leaf Venture Partners, L.L.C. either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 97.8 |
| Others | 2.2 |
New Leaf Venture Partners, L.L.C. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of New Leaf Venture Partners, L.L.C.
New Leaf Venture Partners, L.L.C. has 10 stocks in it's portfolio. ARVN proved to be the most loss making stock for the portfolio. EWTX was the most profitable stock for New Leaf Venture Partners, L.L.C. last quarter.
Last Reported on: 13 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ALEC | alector inc | 1.63 | 339,569 | 1,582,390 | unchanged | 0.00 | ||
| ARVN | arvinas inc | 36.32 | 1,434,720 | 35,337,200 | added | 11.26 | ||
| COGT | cogent biosciences inc. | 2.78 | 250,765 | 2,708,260 | unchanged | 0.00 | ||
| CRNX | crinetics pharmaceuticals inc | 7.40 | 141,000 | 7,205,100 | unchanged | 0.00 | ||
| EWTX | edgewise therapeutics inc | 42.62 | 1,553,660 | 41,467,200 | unchanged | 0.00 | ||
| ITRM | iterum therapeutics plc | 0.39 | 345,020 | 376,072 | added | 255 | ||
| PASG | passage bio | 1.80 | 2,497,920 | 1,748,540 | unchanged | 0.00 | ||
| RCKT | rocket pharmaceuticals inc | 2.86 | 150,706 | 2,783,540 | unchanged | 0.00 | ||
| RLYB | rallybio corporation | 3.97 | 3,301,600 | 3,862,880 | unchanged | 0.00 | ||
| XFOR | x4 pharmaceuticals inc | 0.23 | 335,000 | 224,115 | unchanged | 0.00 | ||